{
  "question": "In an inactive state, a transcription factor subunit awaits an activation signal from the membrane phosphorylation cascade. Upon phosphorylation on the Ser residues in the transactivation domain, it dimerizes, shuttles into the nucleus, and serves in gene transcription. A missense mutation X in the transactivation domain is a recessive loss-of-function mutation. You observe that a heterozygous mutation Y in the dimerization domain acts as a dominant-negative mutation. Which of the following molecular phenotypes is most likely observed in the presence of mutation Y?\n\nA) protein degradation and loss-of-function of the wild-type allele\nB) protein aggregation and loss-of-function phenotype\nC) change of protein conformation and gain-of-function phenotype\nD) loss of protein dimerization and wild-type phenotype\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<A>>>",
  "response_list": [
    "Here is a step-by-step breakdown of the reasoning:\n\n1.  **Understand the Wild-Type (WT) Protein:** The transcription factor subunit needs to perform a series of steps to be active: receive a signal (phosphorylation), form a dimer with another subunit, move into the nucleus, and then activate transcription. Dimerization is an essential step.\n\n2.  **Define Dominant-Negative Mutation:** This is the key concept. A dominant-negative mutation occurs when the mutant protein product interferes with the function of the wild-type protein product in the same cell. This is common for proteins that form dimers or multimers. The mutant subunit can still interact with the wild-type subunit, but the resulting complex (e.g., a WT-mutant dimer) is non-functional. Because the mutant protein \"poisons\" the wild-type protein, the loss-of-function phenotype is observed even when a normal allele is present (hence, it is \"dominant\").\n\n3.  **Analyze Mutation Y:**\n    *   It is in the **dimerization domain**.\n    *   It acts as a **dominant-negative**.\n    *   In a heterozygous individual (with one WT allele and one Y allele), both WT and Y protein subunits are produced.\n    *   Because the mutation is in the dimerization domain, the Y subunit can still bind to a WT subunit, forming a WT-Y heterodimer.\n    *   However, this WT-Y dimer is non-functional. It may fail to shuttle to the nucleus or fail to activate transcription.\n    *   The effect is that the mutant Y protein sequesters the functional WT protein into an inactive complex. This effectively causes a **loss-of-function of the wild-type allele's protein product**.\n\n4.  **Evaluate the Options:**\n    *   **A) protein degradation and loss-of-function of the wild-type allele:** This aligns perfectly with the dominant-negative mechanism. The Y protein's interference causes the WT protein it pairs with to become non-functional (\"loss-of-function of the wild-type allele\"). A malformed dimer is often recognized by the cell's quality control systems and targeted for degradation, which is a plausible mechanism for this loss of function.\n    *   **B) protein aggregation and loss-of-function phenotype:** While a loss-of-function phenotype is correct, aggregation is a specific mechanism where proteins form large, insoluble clumps. The classic dominant-negative model involves the formation of a non-functional \"poison dimer,\" not necessarily large aggregates. So, this is less precise than A.\n    *   **C) change of protein conformation and gain-of-function phenotype:** This is incorrect. A dominant-negative mutation results in a *loss-of-function* phenotype, not a gain-of-function.\n    *   **D) loss of protein dimerization and wild-type phenotype:** If the Y mutant completely lost its ability to dimerize, it could not interfere with the WT protein. The WT proteins would be free to form functional WT-WT dimers. This would result in a *recessive* loss-of-function mutation (like mutation X), not a dominant-negative one. The phenotype in a heterozygote would likely be wild-type, not mutant.\n\nConclusion: Option A provides the most accurate description of a dominant-negative mutation in a dimeric protein. The mutant protein interferes with the wild-type protein, leading to a loss of its function, often through the formation of a non-functional complex that may be targeted for degradation.\n\n<<<A>>>"
  ],
  "user_prompt_list": [
    "In an inactive state, a transcription factor subunit awaits an activation signal from the membrane phosphorylation cascade. Upon phosphorylation on the Ser residues in the transactivation domain, it dimerizes, shuttles into the nucleus, and serves in gene transcription. A missense mutation X in the transactivation domain is a recessive loss-of-function mutation. You observe that a heterozygous mutation Y in the dimerization domain acts as a dominant-negative mutation. Which of the following molecular phenotypes is most likely observed in the presence of mutation Y?\n\nA) protein degradation and loss-of-function of the wild-type allele\nB) protein aggregation and loss-of-function phenotype\nC) change of protein conformation and gain-of-function phenotype\nD) loss of protein dimerization and wild-type phenotype\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<A>>>"
  ],
  "system_message": ""
}